Skin manifestations of suspected COVID-19: complications of the disease or reactivation of latent viral infections
By strategically combining the GHK-Cu GLOW stack with other therapies, you can create a synergistic effect where each treatment supports and amplifies the others
doi:10.1016/bs.pbr.2021.01.028
hGLP-1, pGLP-1, eGLP-1 and Ex-4 (7 M) were incubated with purified human serum in 37 C incubator in the presence/absence of 100 M of DPP-4 inhibitor P32/98 (Santa Cruz Biotech), and aliquots of the reaction solutions were extracted after 0, 3, 6, 9 and 11 h incubation respectively, when TFA (0.1%) was added to terminate the reactions
This binding triggers a cascade of cellular responses that stimulate the release of growth hormone (GH) from the pituitary gland, which subsequently increases circulating insulin-like growth factor-1 (IGF-1) levels